Catalyst Funds Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-800
Closed -$54.5K 1250
2024
Q1
$54.5K Buy
+800
New +$54.5K 0.02% 539